34 results about "Perforated gastric ulcer" patented technology

The invention discloses a traditional Chinese medicine for treating gastric ulcer. The medicine is prepared by the following raw materials by weight: 8-20 parts of Radix Codonopsis, 8-20 parts of Atractylodes macrocephala, 10-25 parts of Chinese yam, 5-15 parts of licorice, 10-20 parts of white hyacinth bean, 10-20 parts of white peony root, 3-10 parts of longan, 10-20 parts of red date, 10-20 parts of rhizoma polygonati, 8-15 parts of polygonatum odoratum, 6-15 parts of catnip, 5-10 parts of pepper, 5-12 parts of dried orange peel, 2-8 parts of Radix Aucklandiae, 3-10 parts of agilawood, 3-10 parts of Nardostachys chinensis Batal, 5-15 parts of millet sprout, 8-15 parts of cuttlebone, 10-25 parts of lotus seed, 5-15 parts of Gorgon fruit, 10-20 parts of pseudo-ginseng, and 15-30 parts ofherba aristolochiae. The traditional Chinese medicine for treating gastric ulcer is formed through scientific compatibility of a plurality of carefully chosen bulk drugs. Effective ingredients of each raw material have mutual influences and synergistic effects so as to play a role in reinforcing spleen and stomach, smoothing the liver and nourishing the blood, stop bleeding and relieving pain, promoting the circulation of qi and dissipating blood stasis, soothing the stagnation of stomach qi, etc. Therefore, the traditional Chinese medicine provided in the invention has very good treatment effects for gastric ulcer patients.

The invention relates to a traditional Chinese medicinal composition for treating gastric ulcer. The traditional Chinese medicinal composition is characterized by being prepared from the following raw materials in parts by weight: 6 to 10 parts of viburnum fordiae, 12 to 14 parts of woodfordia fruticosa, 4 to 6 parts of sand aniseeds, 10 to 12 parts of ivy glorybind herb root, 9 to 11 parts of thyrocarpus sampsonii, 10 to 12 parts of callicarpa bodinieri, 6 to 8 parts of rhizoma alismatis, 15 to 17 parts of dandelion, 20 to 30 parts of loofah seeds, and 8 to 14 parts of licorice. The traditional Chinese medicinal composition has the advantages of good treatment effect, moderate taste, no bitter taste, no side or toxic effect, short treatment course, high curative ratio, and no relapse after healing, and the traditional Chinese medicinal composition is mild and easy to take.

The invention relates to a Chinese medicinal composition for treating gastric ulcer. The Chinese medicinal composition is characterized by being prepared from the following raw materials in part by weight: 10 to 20 parts of virginia moonwort, 10 to 14 parts of seville orange flower, 4 to 6 parts of mottled ardisia stem bark, 4 to 6 parts of Tibet camtschaticum hoffm root, 3 to 5 parts of Chinese artichoke, 4 to 6 parts of yanhusuo, 10 to 14 parts of fineleaf schizonepeta herb, 20 to 30 parts of tangerine peel, 8 to 10 parts of Chinese angelica, 10 to 14 parts of Himalayan teasel root, 15 to 17 parts of India madder root, 10 to 50 parts of Chinese date, 50 to 60 parts of costusroot and 8 to 14 parts of liquoric root. The Chinese medicinal composition has the advantages of good curative effect, moderate taste, no bitter and astringent tastes, mild nature, easiness for administration, no toxic or side effect, short treatment course, high cure rate and relapse prevention after healing.

The invention discloses an oral Chinese traditional medicine prescription for treating gastric ulcer. The invention is characterized in that the medicine is prepared by the raw materials with the following parts by weight: Fructus Aurantii 12g, Cortex Magnoliae Officinalis 12g, Rhizoma Atractylodis Macrocephalae 15g, Fructus Amomi 10g, Rhizoma Pinelliae 10g, Radix Codonopsis Pilosulae 10g, Rosa banksiae 6g, Radix Ophiopogonis 6g, :Rhizoma Dioscoreae 12g and Radix Cyathulae 10g. The raw materials are decocted, one dose for one day, each dose for 2-3 times and 30 days for one period of treatment. The invention has the efficacies of soothing liver, strengthening spleen and recovering the functions of spleen and stomach and has evident effect on gastric ulcer; after the clinical treatment validation, the invention has great effect on the disease.

The invention discloses a traditional Chinese medicinal capsule for treating gastric ulcers and complications thereof. The traditional Chinese medicinal capsule comprises, by weight, 6-12g of raw sea squirts, 4-8g of fritillaria cirrhosa, 9-15g of raw Chinese angelica, 6-12g of raw madder, 4-8g of raw trogopterus dung, 4-8g of prepared myrrh, 10-20g of raw bletilla striata, 6-12g of raw rhizoma corydalis, 4-8g of raw tangerine peels, 6-12g of fried Szechwan chinaberry fruits, 10-20g of parched white peony roots, 4-8g of raw liquorice, 4-8g of raw pseudo-ginseng, 10-20g of raw astragalus membranaceus and 4-8g of raw platycodon grandiflorum. The traditional Chinese medicinal capsule has the advantages that curative effect on gastric ulcer treatment is precise, pharmacological effect is quick and stable, treatment course is short, cure rate is high, patients do not relapse easily after healing, and the capsule is economical, practical and convenient to take and carry.

The invention discloses lactobacillus fermentum Lee capable of preventing gastric ulcers and health-care application of the lactobacillus fermentum Lee. A bacterial strain of which the preservation number is CCTCCM2013512 has strong acid resistance, and the survival rate in artificial gastric juice of which the pH value is 3.0 for three hours reaches 40.48 plus or minus 1.84%, and the survival rate in cholate of which the concentration is 0.3% reaches 60%; the hydrophobicity of lactobacillus fermentum Lee cells also reaches 15.17 plus or minus 6.20%, and the lactobacillus fermentum Lee cells can normally grow in human intestines. By adopting the lactobacillus fermentum Lee, the areas and degrees of the gastric ulcers can be reduced; the secretion of gastric acid is reduced; the levels of somatostatin (SS) and vasoactive intestinal peptide (VIP) factors can be increased by different degrees; the levels of motilin (MOL) and P substance (SP) factors are reduced, and the levels of interleukin-6 (IL-6), interleukin-12 (IL-12), tumor necrosis factors-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) are lowered. The effect similar to omeprazole for treating the gastric ulcers is achieved, and a certain gastric ulcer preventing effect is shown.